- cafead   May 26, 2024 at 12:32: PM
via Novo Nordisk's (NOVOb.CO) Wegovy obesity drug reduced adverse kidney-related events by 22% in overweight and obese people in a large study, according to a new analysis the Danish drugmaker published on Saturday.
article source
article source